Quanterix Corp (QTRX): restructuring charge — Quanterix commits to workforce reduction targeting $18M annual savings post-Akoya integration

Quanterix Corp

Termination plan committed July 18, 2025, to reduce operating costs and preserve cash.
Annualized cash savings expected ~$18.0 million from headcount reductions, substantially completed in Q3 2025.
Severance expenses of ~$2.5 million, all cash expenditures in 2025.
Integration plan to realize synergies from acquisition of Akoya Biosciences, Inc.

item 2.05 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Quanterix Corp announced a restructuring with charges of approximately $2.5 million.

Type: restructuring
Charge: approximately $2.5 million

Exact text from the filing

savings relate to headcount reductions, which are expected to be substantially completed in the third quarter of 2025. The Company expects to incur expenses of approximately $2.5 million, substantially all of which will be cash expenditures incurred in 2025 for severance. The Company’s estimates are based on a number of assumptions. Actual results may differ

View on SEC.gov

6 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

Quanterix Corp filing history →

Source: SEC EDGAR

accession 0001503274-25-000080

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.